Equities

Bio-UV Group SA

Bio-UV Group SA

Actions
IndustrialsElectronic and Electrical Equipment
  • Price (EUR)1.80
  • Today's Change0.008 / 0.45%
  • Shares traded29.84k
  • 1 Year change-28.71%
  • Beta0.2738
Data delayed at least 15 minutes, as of Nov 12 2024 16:27 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bio-Uv Group SAS is a France-based company, which operates as a manufacturer of ultraviolet light water treatment equipment. The Company designs, manufactures and markets systems and concepts of disinfection by ultraviolet light (UV-C) adapted to a number of applications, which enable automatic chlorine-free treatment for residential and collective swimming pools and spas. Bio-Uv Group SAS divides its range of products into two main segments: Individual, which includes residential pools & spas, fish ponds and aquariums and domestic drinking water for human consumption, and Professionals, which includes commercial pools and spas for professionals, water treatment, ballast water treatment, aquaculture, aquariums and fountains, among others.

  • Revenue in EUR (TTM)41.09m
  • Net income in EUR-724.37k
  • Incorporated2010
  • Employees155.00
  • Location
    Bio-UV Group SA850 avenue Louis MedardLUNEL 34403FranceFRA
  • Phone+33 499133911
  • Fax+33 499133919
  • Websitehttps://www.bio-uv.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Corep Lighting SA17.82m552.00k7.41m199.0011.792.727.620.41550.76310.763124.513.30------89,567.84--0.2237--0.392133.3622.453.100.14361.29--0.6211---2.095.49-216.61---11.28--
Munic SA12.89m-1.50m8.00m50.00--0.747.460.6209-0.1671-0.16711.441.210.55341.837.76238,693.90-6.44-7.41-9.32-12.0561.4043.39-11.63-10.550.882-3.160.3245---31.59-0.6078-12,294.08--2.53--
Upergy43.72m788.30k8.04m284.0010.030.53686.340.1840.16950.16959.403.171.332.075.05152,861.902.392.294.323.7644.6543.851.801.531.054.600.31426.921.430.6972-58.38--0.9769--
Egide SA32.96m-3.64m9.42m269.00--1.38--0.2858-0.2236-0.22362.030.3441.221.744.83117,725.00-13.51-7.25-27.54-12.5360.6158.27-11.03-6.780.7504-3.350.6725--8.442.9644.52---15.97--
Enogia SA5.07m-2.46m10.28m51.00--1.29--2.03-0.4721-0.47210.80381.270.3059-1.861.2099,490.20-14.84---24.92--132.79---48.52--1.61-33.870.3339--53.94--43.26------
Made SA-100.00bn-100.00bn12.16m41.00------------------------------------------------4.74---17.67------
Bio-UV Group SA41.09m-724.37k18.54m155.00--0.55497.180.4512-0.0695-0.06954.003.230.58271.727.92256,839.90-1.031.15-1.361.4936.3333.72-1.761.870.82922.020.4376---15.8928.28-94.8321.95-0.0734--
MG International SA60.71m2.78m22.39m108.008.060.65766.310.36890.53810.538111.846.600.96251.802.68562,096.804.4012.027.2618.5032.6432.494.576.861.3836.720.067514.99-14.9910.80-40.6519.048.41--
Arcure SA20.18m2.88m29.82m64.0014.373.786.021.480.35760.35762.521.361.061.565.12380,804.3014.16-8.4919.98-12.8075.2072.8113.38-11.672.073.640.4715--39.6219.573,153.05--18.17--
Balyo SA25.57m-14.73m50.48m169.00------1.97-0.3666-0.36660.6361-0.49080.73891.963.75177,545.80-42.58-25.71-242.54-69.5223.8530.96-57.63-36.490.6128-45.934.68--10.452.77-114.02---37.94--
Forsee Power SA176.88m-14.96m50.80m733.00--0.9003--0.2872-0.2096-0.20962.480.78860.98842.9010.28248,082.80-8.36-25.72-11.28-36.2028.7124.41-8.46-33.191.07--0.5278--54.2449.2114.14--27.39--
We. Connect SA254.69m9.00m56.60m167.006.060.99459.320.22223.173.1789.1519.311.443.055.081,525,074.005.084.7110.2713.0911.2910.963.532.880.96867.480.36711.4611.2116.7021.2017.07--9.86
Lacroix Group SA723.74m-612.00k57.71m3.94k--0.34312.310.0797-0.1159-3.09149.6634.831.232.895.52183,735.70-1.74---3.43--40.28---1.42--0.73122.220.4543--7.55---64.06------
Data as of Nov 12 2024. Currency figures normalised to Bio-UV Group SA's reporting currency: Euro EUR

Institutional shareholders

6.51%Per cent of shares held by top holders
HolderShares% Held
Lazard Fr�res Gestion SASas of 28 Mar 2024380.00k3.67%
OFI Invest Asset Management SAas of 29 Aug 2024150.00k1.45%
Talence Gestion SASas of 30 Aug 202486.60k0.84%
Cr�dit Mutuel Asset Management SAas of 30 Jun 202321.00k0.20%
FPM Frankfurt Performance Management AGas of 30 Aug 202420.00k0.19%
Centaur Fondf�rvaltning ABas of 30 Jun 202410.98k0.11%
Hogep Hoche Gestion Priv�e SAas of 28 Jun 20245.00k0.05%
PROMEPAR Asset Management SAas of 30 Jul 20240.000.00%
CA Indosuez (Switzerland) SAas of 30 Jun 20240.000.00%
More ▼
Data from 28 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.